Funding Shortfalls Pressure Small and Rural Hospitals to Delay Essential Data Security Investments; Survey of 187 Small ...

Compass Pathways has announced that its investigational psilocybin therapy, COMP360, met the primary endpoint in its Phase 3 ...

Annual Reportaap Implantate AG closes financial year 2024 successfully - positive developments despite challenging environment 30.06.2025 / 22:00 CET/CESTThe issuer is solely responsible for the ...

Annual General Meeting GUILDFORD, SURREY / ACCESS Newswire / June 30, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of ...

WASHINGTON, DC / ACCESS Newswire / June 30, 2025 / The not-for-profit Aimed Alliance released a comprehensive new report analyzing how state policies govern step therapy, internal and external appeal ...

CD Genomics has launched its innovative EM-seq Service, a major advancement in sequencing technology that enhances the accuracy and efficiency of genetic analysis. This new service highlights CD ...

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCPFirst-in-human trial of AX-0810 will evaluate safety, tolerability, pharmacokinetics, and target engagement in healthy ...

TURKU, FINLAND / ACCESS Newswire / June 30, 2025 / Faron Pharmaceuticals Ltd. (AIM:FARN)(First North:FARON), a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, ...

PRO isn’t just digitized data collection. It’s real-time, structured, regulatory-grade intelligence, designed to enhance compliance, cut down queries, and keep patients engaged.Despite operating in a ...

A New Perspective on Addiction RecoveryIn the journey to overcome addiction, one size certainly does not fit all. Every individual faces different challenges, circumstances, and needs. While some ...

LUND, SWEDEN / ACCESS Newswire / June 30, 2025 / During June 2025, the number of shares and votes in Alligator Bioscience AB (STO:ATORX) ("Alligator Bioscience")has increased as a result of the ...

As recently announced, initial proof-of-concept results from this ongoing investigator-initiated trial (IIT) show crofelemer reduced the required total parenteral nutrition in the first participating ...